Foley Represents TCGX as Co-Lead Investor in $150M Series B Financing for Alkeus Pharmaceuticals

Foley & Lardner LLP represented TCGX as co-lead investor in the $150 million Series B financing for Alkeus Pharmaceuticals. TCGX was joined by Bain Capital Life Sciences, with additional participation by Wellington Management and Sofinnova Investments. Alkeus Pharmaceuticals is a biopharmaceutical company focused on developing therapies for serious diseases of the eye with high unmet […]